S'abonner

Risk of COVID-19 in health-care workers in Denmark: an observational cohort study - 26/11/20

Doi : 10.1016/S1473-3099(20)30589-2 
Kasper Iversen, ProfDMS a, b, , Henning Bundgaard, ProfDMSc c, Rasmus B Hasselbalch, MD a, b, Jonas H Kristensen, MD a, b, Pernille B Nielsen, MD a, b, Mia Pries-Heje, MD c, Andreas D Knudsen, MD c, d, Casper E Christensen, PhD e, Kamille Fogh, MD a, b, Jakob B Norsk, MD a, b, Ove Andersen, ProfDMSc f, Thea K Fischer, DMSc g, Claus Antonio Juul Jensen, MD h, Margit Larsen, PhD n, Christian Torp-Pedersen, ProfDMSc g, Jørgen Rungby, ProfDMSc i, Sisse B Ditlev, PhD j, Ida Hageman, MD k, Rasmus Møgelvang, PhD c, Christoffer E Hother, MD n, Mikkel Gybel-Brask, PhD n, Erik Sørensen, MD n, Lene Harritshøj, PhD n, Fredrik Folke, ProfPhD l, Curt Sten, MD o, Thomas Benfield, ProfDMSc m, Susanne Dam Nielsen, DMSc d, Henrik Ullum, ProfPhD n
a Department of Cardiology, Herlev og Gentofte Hospital, University of Copenhagen, Herlev, Denmark 
b Department of Emergency Medicine, Herlev og Gentofte Hospital, University of Copenhagen, Herlev, Denmark 
c Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark 
d Department of Infectious Disease, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark 
e Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen, Glostrup, Denmark 
f Department of Emergency and Clinical Research Centre, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark 
g Department of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark 
h Department of Clinical Biochemistry, Nordsjællands Hospital, Hillerød, Denmark 
i Department of Endocrinology and Copenhagen Center for Translational Research, Bispebjerg Hospital, Copenhagen, Denmark 
j Department of Pulmonary Medicine and Copenhagen Center for Translational Research, Bispebjerg Hospital, Copenhagen, Denmark 
k Mental Health Services–The Capital Region of Denmark, Copenhagen, Denmark 
l Emergency Medical Services, Ballerup, Copenhagen, Denmark 
m Department of Infectious Disease, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark 
n Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark 
o Diagnostisk Enhed, Bornholms Hospital, Rønne, Denmark 

* Correspondence to: Prof Kasper Iversen, Department of Cardiology, Herlev Hospital, University of Copenhagen, 2730 Herlev, Denmark Department of Cardiology Herlev Hospital University of Copenhagen Herlev 2730 Denmark

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Summary

Background

Health-care workers are thought to be highly exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to investigate the prevalence of antibodies against SARS-CoV-2 in health-care workers and the proportion of seroconverted health-care workers with previous symptoms of COVID-19.

Methods

In this observational cohort study, screening was offered to health-care workers in the Capital Region of Denmark, including medical, nursing, and other students who were associated with hospitals in the region. Screening included point-of-care tests for IgM and IgG antibodies against SARS-CoV-2. Test results and participant characteristics were recorded. Results were compared with findings in blood donors in the Capital Region in the study period.

Findings

Between April 15 and April 23, 2020, we screened 29 295 health-care workers, of whom 28 792 (98·28%) provided their test results. We identified 1163 (4·04% [95% CI 3·82–4·27]) seropositive health-care workers. Seroprevalence was higher in health-care workers than in blood donors (142 [3·04%] of 4672; risk ratio [RR] 1·33 [95% CI 1·12–1·58]; p<0·001). Seroprevalence was higher in male health-care workers (331 [5·45%] of 6077) than in female health-care workers (832 [3·66%] of 22 715; RR 1·49 [1·31–1·68]; p<0·001). Frontline health-care workers working in hospitals had a significantly higher seroprevalence (779 [4·55%] of 16 356) than health-care workers in other settings (384 [3·29%] of 11 657; RR 1·38 [1·22–1·56]; p<0·001). Health-care workers working on dedicated COVID-19 wards (95 [7·19%] of 1321) had a significantly higher seroprevalence than other frontline health-care workers working in hospitals (696 [4·35%] of 15 983; RR 1·65 [1·34–2·03]; p<0·001). 622 [53·5%] of 1163 seropositive participants reported symptoms attributable to SARS-CoV-2. Loss of taste or smell was the symptom that was most strongly associated with seropositivity (377 [32·39%] of 1164 participants with this symptom were seropositive vs 786 [2·84%] of 27 628 without this symptom; RR 11·38 [10·22–12·68]). The study is registered at ClinicalTrials.gov, NCT04346186.

Interpretation

The prevalence of health-care workers with antibodies against SARS-CoV-2 was low but higher than in blood donors. The risk of SARS-CoV-2 infection in health-care workers was related to exposure to infected patients. More than half of seropositive health-care workers reported symptoms attributable to COVID-19.

Funding

Lundbeck Foundation.

Le texte complet de cet article est disponible en PDF.

Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 20 - N° 12

P. 1401-1408 - décembre 2020 Retour au numéro
Article précédent Article précédent
  • Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
  • The National SARS-CoV-2 Serology Assay Evaluation Group, Mark Ainsworth, Monique Andersson, Kathryn Auckland, J Kenneth Baillie, Eleanor Barnes, Sally Beer, Amy Beveridge, Sagida Bibi, Luke Blackwell, Martyna Borak, Abbie Bown, Tim Brooks, Nicola A Burgess-Brown, Susana Camara, Matthew Catton, Kevin K. Chau, Thomas Christott, Elizabeth Clutterbuck, Jesse Coker, Richard J Cornall, Stuart Cox, David Crawford-Jones, Derrick W Crook, Silvia D’Arcangelo, Wanwisa Dejnirattsai, Julie M M Dequaire, Stavros Dimitriadis, Kate E Dingle, George Doherty, Christina Dold, Tao Dong, Susanna J Dunachie, Daniel Ebner, Marc Emmenegger, Alexis Espinosa, David W Eyre, Rory Fairhead, Shayan Fassih, Conor Feehily, Sally Felle, Alejandra Fernandez-Cid, Maria Fernandez Mendoza, Thomas H Foord, Thomas Fordwoh, Deborah Fox McKee, John Frater, Veronica Gallardo Sanchez, Nick Gent, Dominique Georgiou, Christopher J Groves, Bassam Hallis, Peter M Hammond, Stephanie B. Hatch, Heli J Harvala, Jennifer Hill, Sarah J Hoosdally, Bryn Horsington, Alison Howarth, Tim James, Katie Jeffery, Elizabeth Jones, Anita Justice, Fredrik Karpe, James Kavanagh, David S Kim, Richard Kirton, Paul Klenerman, Julian C Knight, Leonidas Koukouflis, Andrew Kwok, Ullrich Leuschner, Robert Levin, Aline Linder, Teresa Lockett, Sheila F Lumley, Spyridoula Marinou, Brian D Marsden, Jose Martinez, Lucas Martins Ferreira, Lara Mason, Philippa C Matthews, Alexander J Mentzer, Alexander Mobbs, Juthathip Mongkolsapaya, Jordan Morrow, Shubhashish M M Mukhopadhyay, Matthew J Neville, Sarah Oakley, Marta Oliveira, Ashley Otter, Kevin Paddon, Jordan Pascoe, Yanchun Peng, Elena Perez, Prem K Perumal, Timothy E A Peto, Hayleah Pickford, Rutger J Ploeg, Andrew J Pollard, Anastasia Richardson, Thomas G Ritter, David J Roberts, Gillian Rodger, Christine S Rollier, Cathy Rowe, Justine K Rudkin, Gavin Screaton, Malcolm G Semple, Alex Sienkiewicz, Laura Silva-Reyes, Donal T Skelly, Alberto Sobrino Diaz, Lizzie Stafford, Lisa Stockdale, Nicole Stoesser, Teresa Street, David I Stuart, Angela Sweed, Adan Taylor, Hannah Thraves, Hoi P Tsang, Marije K Verheul, Richard Vipond, Timothy M Walker, Susan Wareing, Yolanda Warren, Charlie Wells, Clare Wilson, Kate Withycombe, Rebecca K Young
| Article suivant Article suivant
  • Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
  • Richard Kuehl, Laura Morata, Christian Boeing, Isaac Subirana, Harald Seifert, Siegbert Rieg, Winfried V Kern, Hong Bin Kim, Eu Suk Kim, Chun-Hsing Liao, Robert Tilley, Luis Eduardo Lopez-Cortés, Martin J Llewelyn, Vance G Fowler, Guy Thwaites, José Miguel Cisneros, Matt Scarborough, Emmanuel Nsutebu, Mercedes Gurgui Ferrer, José L Pérez, Gavin Barlow, Susan Hopkins, Hugo Guillermo Ternavasio-de la Vega, M Estée Török, Peter Wilson, Achim J Kaasch, Alex Soriano, International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis, Richard Kuehl, Laura Morata, Christian Boeing, Isaac Subirana, Harald Seifert, Siegbert Rieg, Winfried V. Kern, Hong Bin Kim, Eu Suk Kim, Chun-Hsing Liao, Robert Tilley, Luis Eduardo Lopez-Cortés, Martin J. Llewelyn, Vance G. Fowler, Guy Thwaites, José Miguel Cisneros, Matt Scarborough, Emmanuel Nsutebu, Mercedes Gurgui Ferrer, José L. Pérez, Gavin Barlow, Susan Hopkins, Hugo Guillermo Ternavasio-de la Vega, Estée Török, Peter Wilson, Achim J. Kaasch, Alex Soriano, Christian Bernasch, Norma Jung, Karuna Lamarca Soria, Maria Alba Rivera Martínez, Nuria Prim, José Antonio Martínez, Miguel Marcos, Jesús Rodríguez Baño, Marina De Cueto, Kyoung-Ho Sung, Chung-Jong Kim, Chang Kyung Kang, Jung In Park, Stephen Morris-Jones, Musa Kamfose, Bernadette Young, Hannah Gott, Theodore Gouliouris, Luke Bedford, James Price

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.